Related Experiment Video

Updated: Sep 11, 2025

Author Spotlight: Enhancing Coronary Artery Revascularization
05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

844

Long-term survival after multidisciplinary heart team-guided management of complex coronary artery disease

Taylor Pickering1, Austin Kluis1,2, Emily Shih1,2

  • 1Baylor Scott & White Research Institute, Plano, Texas, USA.

Proceedings (Baylor University. Medical Center)
|August 18, 2025
PubMed

Insights

A multidisciplinary heart team approach for complex coronary artery disease (CAD) showed high adherence to recommendations (92%) and improved patient outcomes. Coronary artery bypass grafting (CABG) demonstrated the lowest mortality rates.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Health Services Research

Background:

  • Guidelines advocate for a multidisciplinary heart team in complex coronary artery disease (CAD) management.
  • However, data on the impact of this approach on clinical outcomes and adherence is limited.

Purpose of the Study:

  • To evaluate the adherence to heart team recommendations and clinical outcomes in high-risk patients with complex CAD.
  • To assess the effectiveness of a multidisciplinary heart team approach in managing complex coronary artery disease.

Main Methods:

  • A prospective study involving 210 high-risk patients with complex CAD evaluated by a heart team.
  • Assessment of adherence to recommendations for coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), hybrid PCI/CABG, or optimal medical therapy (OMT).
  • Clinical outcomes, including 30-day, 1-year, and 2-year mortality, were tracked.

Main Results:

  • High overall adherence to heart team recommendations (92%), with specific rates for CABG (96%), PCI (90%), OMT (87%), and hybrid PCI/CABG (75%).
  • Coronary artery bypass grafting (CABG) was the most recommended treatment (53%) and showed the lowest 1-year (4%) and 2-year (6%) mortality.
  • Percutaneous coronary intervention (PCI) was associated with significantly higher mortality (1-year: 28%, 2-year: 40%) compared to CABG and OMT.

Conclusions:

  • A single-center multidisciplinary heart team approach for complex CAD achieved high adherence and favorable outcomes.
  • This patient-centered model supports the integration of multidisciplinary evaluation into standard practice for high-risk CAD patients.
Abstract

Keywords:
Coronary artery bypass graftingcoronary artery diseaselong-term outcomesmultidisciplinary heart teampercutaneous coronary intervention

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.5K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.1K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32